Crossmark

Correction: Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1038/s41419-026-08740-y

Published Online: 2026-04-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dayanc, Bengisu

Eris, Sude https://orcid.org/0000-0002-2310-8829
Gulfirat, Nazife Ege https://orcid.org/0009-0000-4716-609X
Ozden-Yilmaz, Gulden

Cakiroglu, Ece

Coskun Deniz, Ozlem Silan

Karakülah, Gökhan https://orcid.org/0000-0001-6706-1375
Erkek-Ozhan, Serap

Senturk, Serif https://orcid.org/0000-0003-3963-2294
License Information

Text and Data Mining valid from 2026-04-24

Version of Record valid from 2026-04-24
More Information

Article History

First Online: 24 April 2026